BUY : GLENMARK-EQ( GLENMARK ) [7406]

Glenmark Pharmaceuticals Limited is a strong BUY at ₹1938 with a target price of ₹2131 and stop loss at ₹1745. The company has recently delivered robust Q1FY26 results, showcasing over 120% growth in revenues, supported by solid demand in the US and Indian markets. Expansion in specialty and generics segments, along with a healthy product pipeline, enhances earnings visibility. Strong balance sheet, improving margins, and consistent R&D investments provide further confidence in sustainable growth. With favorable industry outlook, regulatory approvals, and improving operating efficiency, Glenmark is well-positioned to deliver shareholder value, making it an attractive medium-term investment opportunity.